Articles

Philadelphia Fed’s factory gauge jumps in October

Index rises to 10.3, second straight monthly gain

Retail sales post solid gain in September

Sales up 0.4%, above market forecasts

AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease

Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.

Oil prices find a floor after 4-day slide despite disappointing Chinese stimulus

Crude futures appeared to stabilize on Thursday, trading modestly higher after sliding for four sessions. But skepticism surrounding the latest stimulus measures announced by China overnight helped keep a lid on prices, analysts said.

Globe Life targeted by ‘unknown threat actor’ in extortion attempt

Globe Life Inc. has been targeted in an extortion attempt, the life insurance company revealed Thursday.

Sage Therapeutics’ stock lower as biotech unveils plan to cut 33% of workforce

More than 165 jobs to go as company seeks to extend cash runway and focus on postpartum drug launch.

Travelers’ stock leaps toward a record as income triples, profitability improves

ravelers’ stock surges toward another record after earnings beat expectations by a wide margin, amid a sharp improvement in underlying profitability.

Elevance Health’s stock tumbles as profit dented by ‘unprecedented’ Medicaid challenges

“We remain confident in the long-term earnings potential of our diverse businesses as we navigate a dynamic operating environment and unprecedented challenges in the Medicaid business,” Chief Executive Gail K. Boudreaux said in prepared remarks.

NYSE stocks at new highs pump the market — but the VIX is sending mixed signals

S&P 500 looks solid, and charts are positive for Amphenol, APA, wheat and Walgreens.

This presidential candidate is still the stock market’s bet to win the election

The Dow’s indication of who will win the U.S. presidency deserves to be taken seriously.

A French crypto whale backing Trump may be moving markets many times that size

There’s something funny going on in betting markets that seems to be leaking out into banking stocks, the dollar and Treasury yields.

I’m 63, retired and getting $45,000 per year. But I only have about $200,000 in my IRA and still have a mortgage. What’s my move?

Have an issue with your financial adviser or considering a new one? Email questions or concerns to [email protected].
1 849 850 851 852 853 2,474